7/30/2021Financial-related Company News in Brief (July 2021)

7/30/2021Recent Executive Moves

7/29/2021SMEI: Chinese Drug Market under Transformation with Growing ex-Hospita...

7/29/2021Junshi's Chinese sNDA for Toripalimab Plus Chemotherapy as First-Lin...

7/29/2021Eli Lilly hands Kumquat Biosciences $70M to kick off cancer drug R&D a...

7/29/2021Complix Signs Global Drug R&D Pact with Nhwa Pharma to Develop Novel A...

7/29/2021I-Mab's Chinese IND for P2 Trial of Efineptakin Alfa in Combo with PD-...

7/29/2021Health Care in the Year of the Ox: Navigating China's Dynamic M&A Mark...

7/28/2021NHC Issues the Guidelines for Comprehensive Clinical Appraisal of Drug...

7/28/2021Daewoong Reports Positive Chinese Ph3 Trial Outcome of Its Botulinum...

7/27/2021NMPA Revises Packages Insert of Vitamin B6 Injection

7/27/2021NMPA Issues the Announcement on Certain Matters Related to Drug-Device...

7/27/2021HUTCHMED and AZ Initiate Phase II Trial of ORPATHYS for MET Amplified ...

7/27/2021NASDAQ-listed I-Mab to Seek Dual Listing on Shanghai's STAR Market

7/27/2021Sanofi Secures A New Indication for Renvela (sevelamer) in China

7/27/2021Understanding "Internet Plus Healthcare" in China: Policy Text Analysi...

7/23/2021Novartis Reports Strong H1 & Q2 Global and China Performance

7/23/2021Roche Reports Flat H1 Performance with Moderate China Drug Sales Growt...

7/23/2021Menarini AP Acquires China Rights of Cialis (Tadalafil) from Lilly

7/23/2021Recent Executive Moves

7/22/2021Aptamer and WuXi AppTec Collaborate to Identify New Optimer Enabled Th...

7/22/2021Merck and Adagene Ink Trial Collaboration and Supply Agreement for Com...

7/22/2021Mabpharm/Sorrento Granted Chinese Approval for Infliximab Biobetter

7/22/2021Ascletis Granted Chinese Approval of PIII Trial of ASC40 Combo with B...

7/20/2021South Korea's Medipost Drops Joint Venture Plan in China

7/20/2021Eluminex Bio Licenses FibroGen's Biosynthetic Cornea Technology and Re...

7/20/2021Review of Chinese Pharma Deals, R&D and Regulatory Developments in H1/...

7/19/2021Junshi Bio and Immorna Announce JV for mRNA-based Therapeutics and Va...

7/16/2021NHSA Issues the BMI Management Procedures for Disease Group-based Diag...

7/16/2021Recent Executive Moves

Page:89/360 Total number of articles:10791: [First][<<] [87] [88] [89] [90] [91] [>>] [End]